Blueprint Medicines Cash from Financing (TTM) Analysis

Blueprint Medicines Corp (BPMC)

94.90 +3.51 (+3.84%) USD | NASDAQ | May 01, 16:00

94.90 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	119.22M
September 30, 2023	106.19M
June 30, 2023	388.35M
March 31, 2023	560.55M
December 31, 2022	561.81M
September 30, 2022	577.25M
June 30, 2022	207.61M
March 31, 2022	44.97M
December 31, 2021	50.72M
September 30, 2021	252.88M
June 30, 2021	326.30M
March 31, 2021	314.62M
December 31, 2020	617.76M
September 30, 2020	399.50M
June 30, 2020	319.65M
March 31, 2020	648.78M
December 31, 2019	340.64M
September 30, 2019	339.57M
June 30, 2019	335.19M

Date	Value
March 31, 2019	3.403M
December 31, 2018	4.454M
September 30, 2018	331.54M
June 30, 2018	331.80M
March 31, 2018	547.43M
December 31, 2017	543.95M
September 30, 2017	350.72M
June 30, 2017	349.62M
March 31, 2017	132.96M
December 31, 2016	132.58M
September 30, 2016	-2.396M
June 30, 2016	-2.185M
March 31, 2016	152.96M
December 31, 2015	153.22M
September 30, 2015	208.17M
June 30, 2015	208.70M
March 31, 2015	55.82M
December 31, 2014	81.35M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

44.97M

Minimum

Mar 2022

648.78M

Maximum

Mar 2020

342.71M

Average

335.19M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks